In a move designed to reduce the strain on GPs and the wider healthcare system, NHS Bedfordshire CCG and NHS Greenwich CCG (covering a total population of over 700,000 patients) have implemented an innovative software solution capable of triaging patients with MSK related issues such as bad backs and sprains determining the severity of their condition and recommending next stages without the need for a doctors鈥 appointment.
Phio is EQL鈥檚 physiotherapy assessment solution providing an agile triage tool that signposts users into suitable MSK care pathways. This approach reduces the need for human intervention thereby alleviating pressure on GP鈥檚 already under pressure from COVID-19.
More from News
- From Workouts To Managing Jetlag: The British Tech Scale-Up That Just Hit One Million Users Globally Appoints New CEO
- Hackers Tricked Instagram鈥檚 AI To Leak Your Log In Details 鈥 How Can Users Stay Protected?
- New Research Reveals The UK鈥檚 Top 10 鈥淔uture-Ready鈥 Cities
- New Research Shows How Elections Are Impacting The Job Market 鈥 Here鈥檚 How
- Is London Becoming The World鈥檚 Next AI Capital?
- Google鈥檚 AI Can鈥檛 Even Spell 鈥淕oogle鈥 鈥 So Why Is It Replacing Search?
- Will AI Labels Actually Save YouTube From AI Slop?
- The Rise Of 鈥淣ew Brand鈥 Cybercrime Groups And The Business Of Ransomware
Jason Ward, CEO of EQL, who along with Peter Grinbergs co-founded the company, said: 鈥淎t this time it is imperative to alleviate pressure on Primary Care and the wider NHS.聽 We are committed to radically improving clinical pathways through technology and are thrilled to be working with NHS Bedfordshire and Greenwich through Circle Health the specialist healthcare provider.聽 We hope to see other Clinical Commissioning Groups follow suit in the future. 鈥
Accessible 24/7 and available in any language, Phio can complement existing services and is a strong alternative for many telephone-based and remote physiotherapy services. It also offers dramatically improved customer journeys and has the potential to radically improve health outcomes.